Literature DB >> 10585448

The microtubule binding of Tau and high molecular weight Tau in apoptotic PC12 cells is impaired because of altered phosphorylation.

P K Davis1, G V Johnson.   

Abstract

Although the importance of the microtubule network throughout cell life is well established, the dynamics of microtubules during apoptosis, a regulated cell death process, is unclear. In a previous study (Davis, P. K., and Johnson, G. V. (1999) Biochem. J. 340, 51-58) we demonstrated that the phosphorylation of the microtubule-associated protein tau was increased during neuronal PC12 cell apoptosis. The purpose of this study was to determine whether the increased tau phosphorylation that occurred during apoptosis impaired the microtubule binding capacity of tau. This study is the first demonstration that microtubule-binding by tau and high molecular weight tau is significantly impaired as a result of altered phosphorylation during a naturally occurring process, apoptosis. Furthermore, co-immunofluorescence studies reveal for the first time that tau populations within an apoptotic neuronal PC12 cell exhibit differential phosphorylation. In control PC12 cells, Tau-1 staining (Tau-1 recognizes an unphosphorylated epitope) is evident throughout the entire cell body. In contrast, Tau-1 immunoreactivity in apoptotic PC12 cells is retained in the nuclear/perinuclear region but is significantly decreased in the cytoplasm up to the plasma membrane. The selective distribution of phosphorylated tau in apoptotic PC12 cells indicates that tau likely plays a significant role in the cytoskeletal changes that occur during apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585448     DOI: 10.1074/jbc.274.50.35686

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease.

Authors:  Simona Capsoni; Ivan Arisi; Francesca Malerba; Mara D'Onofrio; Antonino Cattaneo; Enrico Cherubini
Journal:  Brain Sci       Date:  2022-06-15

Review 2.  In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease.

Authors:  Nadia Canu; Pietro Calissano
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

3.  β-Amyloid impairs axonal BDNF retrograde trafficking.

Authors:  Wayne W Poon; Mathew Blurton-Jones; Christina H Tu; Leila M Feinberg; Meredith A Chabrier; Joe W Harris; Noo Li Jeon; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2009-06-21       Impact factor: 4.673

4.  New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders.

Authors:  P Vasudevaraju; Erika Guerrero; Muralidhar L Hegde; T B Collen; Gabrielle B Britton; K S Rao
Journal:  J Pharm Bioallied Sci       Date:  2012-04

5.  p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells.

Authors:  Claudie Hooper; Eirini Meimaridou; Mahvash Tavassoli; Gerry Melino; Simon Lovestone; Richard Killick
Journal:  Neurosci Lett       Date:  2007-03-15       Impact factor: 3.046

6.  Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.

Authors:  B P Bouchet; J Bertholon; N Falette; C Audoynaud; C Lamblot; A Puisieux; C M Galmarini
Journal:  Br J Cancer       Date:  2007-10-30       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.